Submission Details
| 510(k) Number | K252623 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 19, 2025 |
| Decision Date | February 04, 2026 |
| Days to Decision | 169 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K252623 is an FDA 510(k) clearance for the G7? Revision Acetabular System, a Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented (Class II — Special Controls, product code LPH), submitted by Zimmer, Inc. (Warsaw, US). The FDA issued a Cleared decision on February 4, 2026, 169 days after receiving the submission on August 19, 2025. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3358.
| 510(k) Number | K252623 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 19, 2025 |
| Decision Date | February 04, 2026 |
| Days to Decision | 169 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | LPH — Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3358 |